Form 8-K - Current report:
SEC Accession No. 0001213900-25-053607
Filing Date
2025-06-12
Accepted
2025-06-12 08:45:29
Documents
21
Period of Report
2025-06-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0245241-8k_citius.htm   iXBRL 8-K 36712
2 FORM OF WARRANT ISSUED ON JUNE 11, 2025 ea024524101ex4-1_citius.htm EX-4.1 94984
3 FORM OF PRE-FUNDED WARRANT ISSUED ON JUNE 11, 2025 ea024524101ex4-2_citius.htm EX-4.2 90767
4 FORM OF PLACEMENT AGENT WARRANT ISSUED ON JUNE 11, 2025 ea024524101ex4-3_citius.htm EX-4.3 96362
5 OPINION OF WYRICK ROBBINS YATES & PONTON LLP ea024524101ex5-1_citius.htm EX-5.1 13019
6 FORM OF SECURITIES PURCHASE AGREEMENT, DATED AS OF JUNE 9, 2025, BY AND AMONG CI ea024524101ex10-1_citius.htm EX-10.1 214604
7 PRESS RELEASE, DATED JUNE 10, 2025 ea024524101ex99-1_citius.htm EX-99.1 12773
8 PRESS RELEASE, DATED JUNE 12, 2025 ea024524101ex99-2_citius.htm EX-99.2 12155
9 GRAPHIC ex99-1_001.jpg GRAPHIC 4472
13 GRAPHIC image_001.jpg GRAPHIC 4472
  Complete submission text file 0001213900-25-053607.txt   896549

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE ctxr-20250609.xsd EX-101.SCH 3026
11 XBRL LABEL FILE ctxr-20250609_lab.xml EX-101.LAB 34239
12 XBRL PRESENTATION FILE ctxr-20250609_pre.xml EX-101.PRE 22366
23 EXTRACTED XBRL INSTANCE DOCUMENT ea0245241-8k_citius_htm.xml XML 3677
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 251041756
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)